Recently, it has been reported that mesenchymal stromal cells (MSC)-derived exosomes can regulate VEGFA and angiogenesis as a potential drug for BPD treatment, but lung fibroblast-derived exosomes did not show any benefit in hyperoxia-induced mice10,11. The gene discussed is VEGFA; the disease is bronchopulmonary dysplasia.